Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Oct 17;61(20):1049-51.
doi: 10.1007/BF01537503.

[Kidney involvement in liver diseases: morphology]

[Article in German]

[Kidney involvement in liver diseases: morphology]

[Article in German]
G Syré. Klin Wochenschr. .

Abstract

Primary liver diseases are often associated with disturbance of the renal function, but only two hepatic lesions are due to glomerular changes: hepatitis B and alcoholic liver disease. Hepatitis B associated with immune complex glomerulonephritis seems to be a rare condition in adults, however children are more often involved. Glomerular changes consist of membranous deposition of immune complexes, mainly corresponding to membranous glomerulonephritis, seldom to the membranoproliferative type. Because membranous glomerulonephritis develops due to deposition of small size soluble complexes, and the hepatitis B antigens alone are estimated to be greater than soluble nephritogenic complexes, most probably low molecular weight antigenic components of the hepatitis antigens are involved in the formation of glomerulonephritis. Alcoholic liver disease is often combined with glomerulosclerosis and mesangial IgA deposition resembling the morphological pattern of IgA mesangial glomerulonephritis. These common features implicate a similar pathogenesis of both diseases. Furthermore, experimental and clinical data indicate raised serum levels of IgA and IgA deposition within glomerula and other organs in the same manner, but the cause of high serum levels of IgA remains still obscure, and may be different in both diseases.

PubMed Disclaimer

Similar articles

References

    1. Ann Intern Med. 1974 Oct;81(4):448-51 - PubMed
    1. Lancet. 1971 Jul 31;2(7718):234-7 - PubMed
    1. Clin Exp Immunol. 1980 Nov;42(2):247-54 - PubMed
    1. Lancet. 1974 Aug 31;2(7879):477-82 - PubMed
    1. Nouv Presse Med. 1979 Apr 28;8(19):1595-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources